The Valley Desk

NCT02274233 · Interventional trial

Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia

Overall registry status Terminated

Phase 1

Conditions Beta-Thalassemia, Iron Overload

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov